“Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia After BTK Inhibitor and/or BCL-2 Inhibitor Failure”, Can Hematol Today, vol. 3, no. 2, pp. 49–53, Jun. 2024, doi: 10.58931/cht.2024.3255.